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Treatment of Failed Articular Cartilage
Reconstructive Procedures of the Knee
A Systematic Review
Joseph D. Lamplot,* MD, Kevin A. Schafer,* MD, and Matthew J. Matava,*† MD
Investigation performed at Washington University, St Louis, Missouri, USA
Background: Symptomatic articular cartilage lesions of the knee are common and are being treated surgically with increasing
frequency. While many studies have reported outcomes following a variety of cartilage restoration procedures, few have inves-
tigated outcomes of revision surgery after a failed attempt at cartilage repair or reconstruction.
Purpose: To investigate outcomes of revision cartilage restoration procedures for symptomatic articular cartilage lesions of the
knee following a previously failed cartilage reconstructive procedure.
Study Design: Systematic review; Level of evidence, 4.
Methods: A literature search was performed by use of the PubMed, EMBASE, and MEDLINE/Ovid databases for relevant articles
published between 1975 and 2017 that evaluated patients undergoing revision cartilage restoration procedure(s) and reported
outcomes using validated outcome measures. For studies meeting inclusion criteria, relevant information was extracted.
Results: Ten studies met the inclusion criteria. Lesions most commonly occurred in the medial femoral condyle (MFC) (52.8%),
with marrow stimulation techniques (MST) the index procedure most frequently performed (70.7%). Three studies demonstrated
inferior outcomes of autologous chondrocyte implantation (ACI) following a previous failed cartilage procedure compared with
primary ACI. One study comparing osteochondral allograft (OCA) transplant following failed microfracture (MFX) with primary OCA
transplant demonstrated similar clinical outcomes and graft survival at midterm follow-up. No studies reported outcomes following
osteochondral autograft transfer (OAT) or newer techniques.
Conclusion: This systematic review of the literature reporting outcomes following revision articular cartilage restoration proce-
dures (most commonly involving the MFC) demonstrated a high proportion of patients who underwent prior MST. Evidence is
sufficient to suggest that caution should be taken in performing ACI in the setting of prior MST, likely secondary to subchondral
bone compromise. OCA appears to be a good revision treatment option even if the subchondral bone has been violated from prior
surgery or fracture.
Keywords: revision cartilage; microfracture; osteochondral allograft; autologous chondrocyte implantation; marrow stimulation
techniques; osteochondral autograft
Articular cartilage defects are common and can be found in
60% to 66% of patients undergoing knee arthroscopy,1,10,24
with full-thickness defects found in approximately 36% of
knees in athletes.14 These lesions are being treated surgi-
cally with an increasing frequency; more than 200,000 pro-
cedures are performed in the United States annually, with
an increase of approximately 5% per year.12,32 This growth
has occurred, in large part, secondary to improving technol-
ogies and a well-established increased risk of osteoarthritis
progression in the setting of these lesions.38,46 Articular
cartilage defects commonly occur in young, active patients
eager to return to a high level of activity. Arthroplasty
options may be limited in these relatively young patients;
therefore, cartilage restoration procedures must be
considered.
Symptomatic full-thickness articular cartilage defects
are currently managed with a variety of procedures
depending on numerous factors, including lesion size and
location, number of defects, surgeon preference, and
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insurance coverage. Currently used treatments include
autologous chondrocyte implantation (ACI),3 osteochondral
autograft transfer (OAT),30 osteochondral allograft
(OCA),11 BioCartilage Extracellular Matrix (Arthrex Inc),
minced juvenile articular cartilage allograft (DeNovo NT
Graft; Zimmer-Biomet Inc),13 prefabricated OCA (Carti-
form; Arthrex Inc), and marrow stimulation techniques
(MST) including drilling, abrasion arthroplasty, and
microfracture (MFX).27,40,48 Other techniques that are
used outside of the United States have been described,
such as Hyalgraft C (Fidia Advanced Biopolymers Labo-
ratories), matrix-induced ACI (Sanofi Bioservices), and
the Cartilage Autograft Implantation System (CAIS;
DePuy Mitek).5
While many studies have reported clinical outcomes fol-
lowing primary cartilage restoration procedures, few stud-
ies have reported outcomes of revision cartilage procedures
following a previously failed cartilage reconstructive proce-
dure. As the number of primary reconstruction procedures
continues to increase,12,32 the number of treatment failures
warranting reoperation will also likely increase. Failure
rates following primary cartilage reconstructive procedures
are significant, ranging from 14% to 43%.‡
Given the methodological difficulties of conducting a pro-
spective, randomized study comparing one or more proce-
dures for revision cartilage restoration, a systematic review
of the existing literature may help guide surgical decision
making in the setting of previously treated, symptomatic
articular cartilage lesions of the knee. Therefore, the purpose
of this study was to investigate the outcomes of revision car-
tilage restoration procedures of the knee following a previ-
ously failed articular cartilage reconstructive procedure.
METHODS
Study Identification
A systematic review was performed according to the
PRISMA (Preferred Reporting Items for Systematic Reviews
and Meta-Analysis) guidelines. A medical librarian assisted
with the creation and execution of the search strategy. The
search identified all articles containing terms related to
(“revision” or “failed”) and (“cartilage” or “chondral” or
“osteochondral”) and “knee.” A literature search was inde-
pendently performed by 2 authors (J.D.L. and K.A.S.) in
December 2017. PubMed, EMBASE, and MEDLINE/Ovid
were searched from their earliest entries through December
1, 2017. Full-length manuscripts of studies to potentially be
included based on title and abstract were then indepen-
dently reviewed by the same 2 authors to verify the meeting
of inclusion criteria. Citations within all included studies
were manually reviewed to identify any additional studies
that may have been missed during the initial database
searches (Figure 1).
Studies were considered for inclusion if they were pri-
mary research articles published in English; evaluated
patients undergoing revision articular cartilage restoration
procedures of any articular surface of the knee; and
reported outcomes using validated outcome measures.
Studies that included patients who underwent concurrent
procedures such as osteotomy, ligamentous reconstruction,
or meniscal surgery were also included because of the fre-
quency of these associated procedures. Studies were
excluded if they did not specify what types of prior cartilage
procedures were performed; results were not reported sep-
arately for patients undergoing revision cartilage restora-
tion procedures and those not undergoing a revision
procedure; results were not reported separately according
to the revision cartilage restoration procedure performed;
the cause of the osteochondral lesion was fracture or oste-
oarthritis; revision treatment was arthroplasty or other
artificial surface replacement; the full-text version was not
available; the study was not published in English; or the
study was either a case report or a review.
Data Extraction
A standardized data sheet was prepared, and all relevant
information and outcome data were extracted from the
included studies by 2 authors (J.D.L. and K.A.S.). indepen-
dently. When necessary, means and measure of dispersion
(standard deviation based on error bars from figures) were
estimated. Collected data included title, author, publication
year, publication journal, study type, level of evidence,
patient population, location of the cartilage lesion, size of
cartilage lesion, type of prior cartilage procedure, type of
revision cartilage procedure, clinical outcome, reoperation
rate, and graft survivorship. Quality assessment of the
included studies was performed using the MINORS (Meth-
odological Index for Non-randomized Studies) checklist.47
Two authors (J.D.L. and K.A.S.) independently reviewed
each study and recorded data on these prespecified forms.
Disagreements were resolved by consensus.
RESULTS
Study Characteristics
Initial searches of PubMed,MEDLINE/Ovid, and EMBASE
returned 495, 267, and 601 records, respectively. Fifty-
three studies underwent full-text review. Following appli-
cation of eligibility criteria, 43 of these studies were
excluded, leaving 10 studies for final inclusion.
Individual study characteristics and patient demograph-
ics of all 10 included studies are summarized in Table 1.
Clinical outcomes from these studies are summarized in
Table 2. Two studies were characterized as level 2 evidence,
two as level 3 evidence, and six as level 4 evidence.25 Qual-
ity assessment using the MINORS checklist can be seen in
Appendix Table A1. The mean score using the MINORS
checklist was 12.9 (SD, ±3.3; range, 10-20). The final analy-
sis contained 608 knees. Mean age ranged from 24 to
37.4 years. Minimum follow-up ranged from 1 to 10 years.
Heterogeneity in lesion location was noted, with 52.8% of
the lesions occurring within the medial femoral condyle
(MFC). A variety of failed index cartilage procedures were‡References 19, 20, 25, 33, 34, 37, 39, 49, 52, 53.
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performedprior to therevisioncartilagesurgery. In6studies,
no concomitant procedures were performed.19,20,25,37,39,52 In
the 4 other studies, concomitant procedures were performed
(Appendix Table A2).33,34,49,53 In 3 studies, a considerable
number of patients underwent concomitant procedures.33,34,53
Due to marked heterogeneity in outcome measures, previ-
ous cartilage procedures performed, lesion location, and
definition of treatment failure, a formal meta-analysis
could not be reliably performed.
Autologous Chondrocyte Implantation
Five studies reported outcomes for ACI33,34,39,52,53 following
a failed index cartilage procedure (Table 1). Lesion size was
similar among 4 of these studies, ranging from a mean of
4.5 to 5.2 cm2; one study34 reported a larger mean size of 8.4
cm2. Only one study reported outcomes of revision following
a failed primary ACI.52 Four studies reported outcomes of
ACI following prior MST. Three comparative studies dem-
onstrated inferior outcomes of ACI following prior MST
compared with primary ACI.33,34,39 Two studies performed
subanalysis of patients with prior MFX (excluding other
MSTs33,39), and inferior outcomes were demonstrated in
both studies among patients who underwent prior MFX
compared with primary ACI. One study that analyzed
patients who underwent concomitant high tibial osteotomy
(HTO) and ACI with or without prior MFX33 demonstrated
inferior outcomes among those with prior MFX. Together,
the results of these studies suggest inferior outcomes of ACI
following a previous failed cartilage procedure compared
with primary ACI, particularly following prior MST
including MFX.
Osteochondral Allograft
Three studies investigated outcomes of OCA transplant fol-
lowing a prior failed cartilage procedure.19,20,25 Mean lesion
size in these 3 studies was higher than in those studies
reporting outcomes of ACI following a prior failed cartilage
procedure, with lesion size ranging from amean of 6.8 to 9.5
cm2. While 2 case series lacked a comparative group,20,25
one study compared primary OCA transplant with OCA
transplant following prior failed MST.19 While the reoper-
ation rate was higher among patients undergoing OCA
transplant following prior failed MST, failure rates
between groups did not differ, and survivorship was nearly
Figure 1. PRISMA flow diagram. OA, osteoarthritis.
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identical at 10 years (87.4% for primary OCA vs 86% for
revision OCA, P ¼ .841). Two other studies20,25 without
comparative groups demonstrated varying results, which
may be attributable to lesion size and prior cartilage
procedure performed. In a cohort of patients undergoing
revision OCA transplant following prior OCA transplant
with a mean lesion size of 9.5 cm2, Horton et al25 reported
a failure rate of 39%, with a mean graft survival of
10 years. Gracitelli et al20 reported a cohort of patients
who underwent OCA transplant following a prior failed
cartilage procedure (88.4% had prior MST), noting a
10-year and 15-year graft survivorship of 82% and
74.9%, respectively. Together, the findings of these studies
suggest good midterm survivorship of OCA following prior
cartilage procedures. OCA transplant following prior MST
does not appear to affect graft survival as it does for ACI
following prior MST.
Other Cartilage Repair Techniques
Two studies reported outcomes following cartilage repair
techniques other than ACI or OCA transplant following
a prior failed procedure. Stone et al49 reported on the use
of osteochondral grafting following failed osteochondritis
dissecans repair using morselized autologous osteochon-
dral plugs harvested from the intercondylar notch. A
relatively high reoperation rate was noted, with 71.4%
undergoing revision surgery. Niethammer et al37 demon-
strated improvements in clinical outcome measures
using multiple treatments, including retrograde drilling
and infusion therapy as well as MFX or drilling follow-
ing third-generation ACI. Due to a limited number of
studies using these techniques, further study is needed
to determine their utility in the setting of revision carti-
lage restoration.
TABLE 1
Study Characteristicsa
Lead Author
(Year)
Site of Lesion (%
Population)
Minimum
Follow-up,
y
No. of
Knees
MST
Knees,
% Age, y, mean Prior Cartilage Procedures
Revision
Cartilage
Procedure
Defect Size,
cm2, mean Outcome Measures LOE
Minas33 (2009) Not reported 2 111 100 35.4 (range, 14-55) MST (drilling, abrasion
chondroplasty, microfracture)
(100%)
ACI 5.2 (SD, ±3.1) Treatment failure 2
Minas34 (2014) Not reported 10 89 100 35.8 (SD, ±9.6)b Drilling (52%), abrasion
arthroplasty (34%),
microfracture (14%)
ACI 8.4 (SD, ±5.5)b Graft failure,
WOMAC, KSS,
SF-36
4
Pestka39 (2012) MFC (57%), LFC (7%),
PF (36%)
1 28 100 34.1 (range,
14.8-45.8)
Microfracture (100%) ACI 4.6 (SD, ±2.7;
range,
1.5-7.5)
IKDC, KOOS, VAS
pain, VAS knee
function, ARS
3
Vijayan52 (2014) MFC (50%), LFC (9%),
PF (41%)
1.3 22 0 37.4 (range, 18-48) ACI (77%), MACI (23%) ACI 4.5 (range,
1.5-8.8)
Cincinnati, Stanmore
Bentley, VAS
4
Zaslav53 (2009) MFC (67%), LFC (18%),
PF (16%)
3.8 126 44 34.5 (SD, ±8.1) Debridement (48%),
microfracture (27%), drilling
(10%), abrasion arthroplasty
(6%), other (9%)c
ACI 4.6 (SD, ±3.2) Modified Cincinnati,
KOOS, VAS, SF-36
2
Gracitelli19 (2015) MFC (61%), LFC (31%),
MFCþLFC (7%),
PF (4%)
2 46d 100e 26.2 (SD, ±10.4) MST (microfracture or drilling)
(100%)
OCA 8 (SD, ±3.2)e Merle d’Aubigne-
Postel, IKDC,
KOOS, KSS-F
3
Gracitelli20 (2015) MFC (45%), LFC (17%),
PF (12%), multiple
sites (25%)
2 164 88 32.6 (range, 11-59) MST (88%), OAT (2%), multiple
procedures (7%)
OCA 6.8 (SD, ±8) Merle d’Aubigne-
Postel, IKDC,
KOOS, KSS-F
4
Horton25 (2013) MFC (42%), LFC (27%),
PF (27%), TP (15%)f
2 33 0 33.0 (range, 16-64) OCA (100%) OCA 9.5 (range,
2-30)b
IKDC, KSS-F,
modified Merle
d’Aubigne-Postel
4
Stone49 (2014) MFC (71%), LFC (29%) 2 7 29 24.0 (range, 15-39) OCD repair (43% refixation,
29% drilling, 29% OAT)
OCG 3.3 (SD, ±1.5) IKDC, WOMAC, Raw
Tegner, MRI
analysis
4
Niethammer37
(2015)
MFC (37%), LFC (6%),
PF (56%)b
2 28 0 34.1 (range, 11-66)b ACI Retrograde
drilling or
microfractureg
5 (SD, ±2.5) IKDC, VAS 4
aACI, autologous chondrocyte implantation; ARS, Activity Rating Scale; IKDC, International Knee Documentation Committee; KOOS,
Knee injury and Osteoarthritis Outcome Score; KSS, Knee Society Score; KSS-F, Knee Society Score–Function; LFC, lateral femoral condyle;
LOE, level of evidence; MACI, autologous cultured chondrocytes on porcine collagenmembrane; MFC, medial femoral condyle; MRI, magnetic
resonance imaging; MST, marrow stimulation technique; OAT, osteochondral autograft transfer; OCA, osteochondral allograft; OCD, osteo-
chondritis dissecans; OCG, osteochondral grafting (notch plugs harvested, morselized, and then impacted); PF, patellofemoral; SF-36, Short
Form Health Survey–36; TP, tibial plateau; VAS, Visual Analog Scale; WOMAC, Western Ontario and McMaster Universities Osteoarthritis
Index.
bData for entire study population of index and revision procedures.
cOther: OAT (5%), chondroplasty (2%), MST unspecified (1%).
dIncluded in 164 patients in the Gracitelli et al20 study.
eGraft area (defect area not reported).
fTotal >100%, as some patients had multiple graft sites.
gRetrograde drilling or microfracture: (1) retrograde drillingþ infusion therapy for bone marrow edema; (2) microfracture for partial graft
cartilage deficiency.
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TABLE 2
Study Resultsa
Lead Author
(Year)
Revision
Cartilage
Procedure Clinical Outcomes
Reoperation,
%
Graft
Survivorship, %
Minas33 (2009) ACI Defects with prior treatment affecting subchondral bone failed
at a rate 3 times higher than nontreated defects.
Failure rates of ACI were 28% following drilling, 27% following
abrasion arthroplasty, and 20% following microfracture.
Not
reported
74% at
minimum 2 yb
Minas34 (2014) ACI Survivorship of ACI was lower after prior MST compared with no prior
MST at 10 y (95% CI, 55%-75% vs 76%-90%) and 15 y (95% CI, 50%-
72% vs 69%-87%).
Significant difference in 15-y survivorship following prior microfracture
comparedwith no prior microfracture (95%CI, 17%-68% vs 69%-87%).
Among patients treated with concurrent HTO, 29% with prior MST
experienced failure compared with none without prior MST
(P < .001).
68 71% at 10 y
Pestka39 (2012) ACI ACI following microfracture, when compared with primary ACI, had the
following results, respectively: failure rate 25% vs 3.6% (P ¼ .0241),
IKDC 58.4 vs 69.0 (P ¼ .0583), KOOSpain 69.2 vs 80.1 (P ¼ .034),
KOOSADL 78.5 vs 86.3 (P ¼ .024), VASknee function 6.2 vs 6.9 (P ¼ .032).
25 75% at
minimum 1 y
Vijayan52 (2014) MACI (78%),
ACI (22%)
Modified Cincinnati score from 40.5 to 64.9, VAS from 6.1 to 4.7, 64%
“good” or “excellent” outcome.
36 86% at
minimum1.3 y
Zaslav53 (2009) ACI Significant improvement in all KOOS subscales, modified Cincinnati
3.3 to 6.3, VAS 28.8 to 69.9, SF-36 physical health 33.0 to 44.4.
Duration of benefit 31 months longer following revision ACI than
non-ACI index procedure.
49% had subsequent procedures, which was not predictive of failure.
49 76%b at 4 y
Gracitelli19
(2015)
OCA Reoperation in 24% of primary OCA compared with 44% of OCA after
prior MST (P ¼ .04).
OCA failure in 11% of primary OCA compared with 15% of OCA after
prior MST (P ¼ .53).
10-y survivorship 87.4% following primary OCA compared with 86% in
OCA after prior MST.
Satisfaction 87% in primary compared with 97% in OCA after priorMST.
Significant improvements in pain and function (modified Merle
d’Aubigne-Postel, IKDC, KOOS) with no significant between-group
difference.
44 86% at 10 y
Gracitelli20
(2015)
OCA Median time to failure 2.6 ± 6.8 y.
89% “extremely satisfied” or “satisfied.”
Significant improvement inmodifiedMerle d’Aubigne-Postel, IKDCpain,
function, total, KSS-F, and KOOS postoperatively compared with
preoperatively.
42 82% at 10 y
74.9% at 15 y
Horton25 (2013) OCA Mean time to failure of 5.5 y. Among those with graft survival: 63%
“excellent” or “good” based on Merle D’Aubigne-Postel score, 95%
satisfaction rate with 68% “extremely satisfied.”
67 79% at 5 y
61% at 10 y
Stone49 (2014) OCG Significant improvement in IKDC, WOMAC, and Tegner
postoperatively compared with preoperatively.
Complete cartilage fill and adjacent tissue integration onMRI in 71.4%.
71 57.1%c at
minimum 2 y
Niethammer37
(2015)
Retrograde
drilling or
microfractured
Improvement in IKDCsubjective, VAS during activity, and VAS
at rest postoperatively compared with preoperatively.
Not
reported
Not reported
aACI, autologous chondrocyte implantation; ADL, activities of daily living; HTO, high tibial osteotomy; IKDC, International Knee Doc-
umentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score; KSS-F, Knee Society Score–Function; MACI, autologous
cultured chondrocytes on porcine collagen membrane; MRI, magnetic resonance imaging; MST, marrow stimulation technique; OCA, osteo-
chondral allograft; OCG, osteochondral grafting (notch plugs harvested, morselized, and then impacted); SF-36, Short Form Health Survey–
36; VAS, visual analog scale; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
bDid not meet a priori definition of treatment failure.
cOne patient had partial revision of graft and is included as failure.
dRetrograde drilling or microfracture: (1) retrograde drillingþ infusion therapy for bone marrow edema; (2) microfracture for partial graft
cartilage deficiency.
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DISCUSSION
In our review of the literature, we identified 10 studies
reporting the clinical outcomes of revision articular carti-
lage procedures following failed cartilage restoration
surgery. A high proportion of these patients (70.7%) under-
went previousMST (MFX, drilling, abrasion chondroplasty/
arthroplasty) likely because of the ease, familiarity, and
low cost of these techniques. Although no study directly
compared outcomes of ACI and OCA transplant following
prior failed MST, several of the included studies did report
mid- to long-term graft survival or failure rates. In a study
of 164 knees, of which 88% had undergone prior MFX,
Gracitelli et al20 reported 88% and 82% survivorship at 5
and 10 years, respectively, following OCA transplant. In a
separate study, Gracitelli et al19 performed a matched-
pairs analysis comparing a group of patients undergoing
primary OCA transplant with a group undergoing OCA
transplant after failed MFX. The investigators found a
near-equivalent 10-year graft survivorship between these
2 groups (87.4% and 86%, respectively; P ¼ .841). However,
the group receiving anOCA after failed prior treatment had
nearly double the reoperation rate compared with those
undergoing primary treatment (24% vs 44%), with more
than 50% of these reoperations being an arthroscopic
debridement. Finally, in a recent study not meeting the
inclusion criteria of this review, Frank et al16 demonstrated
no significant difference in 10-year OCA graft survival
when comparing patients with and without a history of
prior MFX, with survival rates of 89.9% and 84.9%, respec-
tively (P ¼ .370). Furthermore, neither concomitant menis-
cal allograft transplant nor the compartment of OCA
transplant (MFC, lateral femoral condyle, or multiple sites)
was found to significantly affect graft survivorship.
Together, these studies suggest that similar results can
be achieved following primary OCA transplant or revision
OCA transplant after previous failed cartilage procedures,
most notably MST.
ACI following prior MST appears to have inferior results
compared with primary ACI. Zaslav et al53 reported a 24%
treatment failure at a minimum 4-year follow-up of patients
who underwent prior cartilage surgery, although fewer
than 50% of their patients underwent prior MST. Pestka
et al39 reported a 25% graft failure at a minimum 15-
month follow-up among patients with prior MFX, with only
a 3.6% failure rate among those undergoing primary ACI
(P ¼ .024). Similarly, Minas et al33 found that patients
undergoing ACI after prior MST had a significantly higher
failure rate than those undergoing ACI without prior MST
(26% vs 8%, P < .001). Failure rates among the different
types of MST (eg, drilling, abrasion arthroplasty, MFX)
were not significantly different. In that study, Minas
et al33 defined “simple” defects as single lesions less than
4 cm2 on the femoral condyles. “Complex” lesions were
either multifocal, single lesions larger than 4 cm2 or those
involving the trochlea, tibia, or patella. “Salvage” lesions
were defined as those occurring on articulating surfaces
(bipolar) or lesions with early arthritic changes. Overall
failure rates were 3 times higher in knees with prior mar-
row stimulation, but the numbers were too low to report
outcomes of “simple” lesions alone. In a separate study,
Minas et al34 demonstrated that survivorship of ACI was
significantly lower following MST at 10- and 15-year
follow-up, with failure rates of 34% and 38%, respectively,
compared with 16% and 21%, respectively, among
patients who did not undergo prior MST. Considering
MFX, alone, the authors reported a 56% graft failure rate
at 15-year follow-up among patients with prior failed MFX
compared with 21% among patients who did not undergo
prior MFX. Finally, among patients who underwent con-
current HTO with ACI, those who underwent prior failed
MST had a significantly higher failure rate (29%) com-
pared with those who did not undergo prior MST (0%).
Collectively, these findings suggest that caution should
be taken when ACI is considered as a treatment option
after a failed prior MST.
Multiple studies have suggested that MST techniques
induce changes to the subchondral architecture similar to
those in osteoarthritis, resulting in a thickened and stiffer
subchondral plate that may be less receptive to cell-based
therapies such as ACI.33,41 In contrast, OCA techniques
replace this altered subchondral bone in the setting of
prior MST or subchondral injury, thereby addressing both
the articular cartilage and osseous components of injury.
Therefore, when ACI is considered in the setting of one or
more previous failed cartilage procedures, prior operative
notes should be thoroughly reviewed, if available, and any
advanced imaging should be carefully scrutinized for signs
of subchondral osseous changes. In addition to potentially
limiting treatment options in the revision setting, index
MFX has been shown to have inferior outcomes compared
with primary ACI and OAT, especially for chronic lesions
or those occurring in patients older than 30 years.2,8,9,22,44
Although cost-effective,45 MFX and other MSTs may need to
be reconsidered as primary cartilage restoration procedures.
In the setting of prior subchondral injury or treatment
involving violation of the subchondral bone such as MST,
the senior author (M.J.M.) uses OAT for lesions less than
approximately 2 cm2 and uses OCA for lesions larger than
2 cm2, for multiple lesions, and for lesions without stable
surrounding bone architecture.30 Microfracture or other
MSTs are used exclusively in younger patients (<30 years)
with small, acute unipolar lesions or for defects located
peripherally on either femoral condyle or central trochlea.
While limited data exist regarding outcomes of treatment
using relatively new technologies, these newer, unproven
graft options may have a role in the revision set-
ting.4,7,13,15,42,50,51 This is especially true for patellar or
trochlear lesions, where it may be technically difficult to
contour osteochondral autograft or allograft plugs. Unfortu-
nately, no long-term follow-up is available for these newer
technologies, and their feasibility may be limited by govern-
mental regulatory agencies and/or third-party payers.
Evaluation of Treatment Failure
The management of symptomatic patients with a failed
reconstructive articular cartilage procedure is challenging
and requires a careful approach. Several factors must be
considered, including the index procedure; the location,
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size, and number of lesions; the cause of failure; the symp-
tom complex; physical examination and imaging results;
and concurrent injury or disease. Surgical planning for
symptomatic patients depends on an understanding of the
multiple causes of treatment failure. Failure of primary
cartilage reconstructive surgery can result from recurrent
trauma, failure of graft incorporation, poor surgical tech-
nique, untreated concomitant injury or disease, or a combi-
nation of these factors. Risk factors for failure following
various cartilage reconstruction procedures have been pre-
viously described.§ Obesity (defined as a body mass index
>30), age older than 45 years, higher preoperative activity
scores, and lesions larger than 2 to 4 cm2 have been found to
be risk factors for failure after MFX.17,18,21,26,29,35 Risk
factors for failure following ACI include obesity, higher
preoperative activity levels, and female sex.6,7,18,23,28,36
First-generation ACI using a periosteal patch has led to a
higher reoperation rate compared with newer ACI techni-
ques.18 Advanced age has been found to be the sole risk
factor for failure following OAT and OCA transplant.31,43
History and Physical Examination
A complete history should be obtained, including mecha-
nism of injury (if any), symptom complex (swelling,
giving-way, locking, catching, crepitus, gait alteration),
symptom duration, previous injuries, and surgical inter-
ventions including ligamentous, meniscal, alignment, and
articular cartilage procedures. Current symptoms should
be compared with those preoperatively. If the patient
describes recurrent symptoms and is unable to recall a
causative traumatic episode, this may suggest technical
or biological reasons for graft failure. The patient should
be asked to describe the postoperative course following the
previous cartilage procedure, detailing the time course and
return to activity or sport. Failure to return to the same
level of activity may suggest a technical error, inadequate
rehabilitation, or failure of graft maturation or incorpora-
tion. Previous operative notes, clinic notes, therapy notes,
imaging studies, and intraoperative arthroscopic images
should be reviewed, if available. A complete physical exam-
ination should be performed, including an assessment of
gait, limb alignment, location of preexisting scars, and lig-
amentous integrity.
Imaging
Plain radiographs, including weightbearing 40 posteroan-
terior (Rosenberg), 30 lateral, and Merchant patellofemoral
views, should be obtained in all patients. Full-length lower
extremity radiographs should be obtained to assess the
mechanical axis, which may alter the operative tactic to
include either a distal femoral osteotomy (DFO) or HTO for
associated coronal malalignment. In the setting of patellofe-
moral instability or dysplasia, an assessment of patellar
height and alignment is imperative prior to any concurrent
patellar realignment procedure. A complete discussion of
these conditions and their treatment is beyond the scope of
this systematic review.
We routinely obtain 1.5-T or 3.0-T magnetic resonance
imaging (MRI) to assess the cartilage lesion as well as
any additional intra-articular abnormality. An MRI is
useful to evaluate the lesion diameter, lesion depth, and
health of the subchondral bone. Computed tomography
(CT) can be useful to better evaluate any congenital or
traumatic structural irregularities of the osseous archi-
tecture. MRI or CT may be used to calculate the tibial
tubercle–trochlear groove distance in patients with
symptomatic patellar instability. Skeletal scintigraphy
(bone scan) is rarely indicated to evaluate discordant
pain patterns in patients presenting with coexistent
articular cartilage lesions.
If a complete understanding of the causes of treatment
failure and the extent of the cartilage lesion cannot be
discerned following a comprehensive history, physical
examination, and review of imaging, then diagnostic
arthroscopy may be indicated. However, in most cases,
diagnostic arthroscopy alone, without a definitive treat-
ment plan, is not indicated. Limb malalignment affecting
the involved compartment in which the chondral lesion is
located should be addressed. Untreated malalignment
may either contribute to or, in some cases, be the sole
cause of treatment failure. In 3 studies included in this
systematic review,33,34,53 a relatively high proportion of
patients underwent realignment osteotomies concurrently
with revision cartilage restoration. In the setting of mala-
lignment, which preferentially loads the compartment
affected by the symptomatic chondral lesion, we advocate
a realignment procedure (HTO, DFO, or tibial tubercle
osteotomy) either concurrently or prior to the revision car-
tilage procedure. A staged procedure may also be consid-
ered if the surgeon does not feel comfortable performing
both the realignment and articular cartilage procedures at
the same setting. Similarly, any ligamentous insufficiency
or meniscal abnormality should be addressed concurrently
with, or prior to, any revision cartilage procedure.
Revision cartilage surgery may be categorized based on
the index procedure and subcategorized based on lesion
location (tibiofemoral or patellofemoral). Furthermore, the
clinician must consider whether the subchondral bone has
been affected by injury or prior treatment. In the setting of
a prior MST, OAT, or OCA, the subchondral bone should be
considered violated, and caution should be taken when ACI
is contemplated in these patients.33,34,39,53
In the setting of a failed primary MST, an OAT or OCA
transplant should be considered; OAT is generally recom-
mended for lesions 2 cm2 or smaller, and OCA is used for
larger lesions. This recommendation is based on an
“average” sized knee, as a smaller knee may not provide
enough osteochondral plugs to fill a 2-cm2 lesion. In this
situation, one or more plugs may also be harvested from
the contralateral knee. Although no data are available to
support the use of prefabricated OCAs in the revision set-
ting, products such as the Cartiform graft, BioCartilage
Extracellular Matrix, and DeNovo NT Graft offer flexibility
in shaping the graft to a variety of surface contours (ie,§References 6, 7, 17, 18, 21, 23, 26, 28, 29, 35, 36.
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patellofemoral surfaces) while maintaining the natural
cartilage-bone interface.
In the setting of a failed ACI procedure, the health of the
subchondral bone must be considered. For lesions that
entail compromised subchondral bone, the treatment
options are similar to those following a failed MST. Regard-
ing healthy subchondral bone, current evidence does not
demonstrate superiority of OAT, OCA, or ACI. However,
our preference is to use either OAT or OCA (depending on
lesion size and graft availability) due to the high cost of ACI
and required 2-stage procedure.45
In the setting of a failed OAT or OCA, revision options
are limited, as the subchondral bone has been violated dur-
ing the index procedure. Similar to revision following other
failed index cartilage procedures, graft choice is largely
based on lesion size. In the setting of a failed OCA, the
indication for the index procedure, the health of the sur-
rounding cartilage and other compartments, and patient
age and activity demands should be considered.25 Horton
et al25 demonstrated a trend toward increased failure rates
in older patients and those whose index procedure was per-
formed as a salvage operation for osteoarthritis. Caution
should be taken with these patients, and arthroplasty
options should be considered depending on age and activity
level.
Limitations
Limitations of the current systematic review include only
10 studies meeting the inclusion criteria and only 608
knees constituting the entire study group. Given the num-
ber of articular cartilage procedures performed in the
United States each year, this is a relatively small number
of patients on which to base a treatment algorithm. Related
to this is the fact that 6 of the 10 studies were level 4 evi-
dence, only 2 studies were level 2, and none were level 1.
Therefore, the majority of studies were case series, with the
inherent limitations associated with nonrandomized, retro-
spectively collected data. Several studies33,34,49,53 included
patients who underwent concurrent ligamentous or menis-
cal procedures, which likely contributed to clinical improve-
ment among those patients undergoingmultiple concomitant
or staged procedures with revision cartilage restoration
(Appendix Table A2). Minimum follow-up varied between
studies, with a range from 1 to 10 years. Follow-up less than
5 years is a potential weakness of any study evaluating the
outcome of an articular cartilage procedure. The studies
entailed a relative lack of variety in terms of the primary
cartilage repair, as themajority involvedanMSTandapprox-
imately 94% (573/608) of the revision procedures were either
ACI or OCA. As well, lesion size was heterogeneous among
the included studies. The years of inclusion of this systematic
review, from 1975 to 2017, comprise a long time span, and
technologies used in the 1970s through the 1990s may not be
applicable in today’s practice. In fact, all 10 studies were pub-
lished between 2009 and 2015. However, any comprehensive
literature searchmust include awide range of years. Finally,
we found no studies evaluating the outcome of newer techni-
ques for cartilage restoration in the revision setting.
Therefore, our conclusions and recommendations must be
interpreted within this context.
CONCLUSION
This systematic review of the literature reporting outcomes
following revision articular cartilage restoration procedures
(most commonly involvingtheMFC)demonstrated thatahigh
proportion of patients underwent prior MST. Evidence is suf-
ficient to suggest that caution should be taken in performing
ACI in the setting of prior MST due to its negative effects on
the subchondral bone. OCA transplant appears to be a good
treatment option in the setting of a failed prior cartilage res-
toration surgery, even if the subchondral bone has been vio-
lated from prior surgery or fracture. Further investigation is
needed to assess outcomes following osteochondral autografts
in the revision setting as well as newer techniques.
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APPENDIX
TABLE A2
Concomitant Procedures Performed During
Revision Cartilage Restoration Procedurea
Lead Author (Year) Concomitant Procedures
Minas33 (2009) 23 (21%) varus/valgus osteotomy
30 (27%) TTO
9 (8%) ligament reconstruction
Minas34 (2014) 33 (15.7%) HTO
3 (1.4%) DFO
49 (23.3%) TTO
15 (7.1%) HTO/TTO
12 (5.7%) ligament reconstruction
18 (8.6%) meniscal procedures
Pestka39 (2012) None
Vijayan52 (2014) None
Zaslav53 (2009) 13 (8%) TTO
11 (7%) lateral release
9 (6%) other (see text)
5 (3%) HTO
1 (1%) loose body removal
1 (1%) partial lateral meniscectomy
1 (1%) synovectomy
Gracitelli19 (2015) None
Gracitelli20 (2015) None
Horton25 (2013) None
Stone49 (2014) 1 (14%) lateral meniscus allograft
Niethammer37 (2015) None
aIncludes all patients in study, not only revisions. DFO, distal
femoral osteotomy; HTO, high tibial osteotomy; TTO, tibial tubercle
osteotomy.
TABLE A1
MINORS Quality Assessmenta
Endpoints
Appropriate
to Aim of
Study
Prospective
Calculation
of Study
Size
For Comparative Studies Only
Lead Author
(Year)
Clearly
Stated
Aim
Inclusion of
Consecutive
Patients
Prospective
Data
Collection
Unbiased
Assessment
of Study
Follow-up
Period
Appropriate
Loss of
Follow-up
<5%
Comparative
Study
Adequate
Control
Contemporary
Groups
Baseline
Equivalence
Groups
Adequate
Statistical
Analysis
Total
Score
Minas33 (2009) 2 2 2 2 0 1 2 1 Yes 2 2 2 2 20
Minas34 (2014) 2 2 2 2 0 2 2 0 No 12
Pestka39 (2012) 2 2 0 2 0 1 2 0 Yes 2 2 2 2 17
Vijayan52 (2014) 2 2 2 1 0 1 2 0 No 10
Zaslav53 (2009) 2 2 2 2 0 2 0 2 No 12
Gracitelli19 (2015) 2 2 0 2 0 1 0 0 Yes 2 2 2 2 15
Gracitelli20 (2015) 2 2 2 2 0 1 2 0 No 11
Horton25 (2013) 2 2 2 2 0 2 0 0 No 10
Stone49 (2014) 2 2 2 2 0 1 2 0 No 11
Niethammer37
(2015)
2 2 2 2 0 1 2 0 No 11
aThe items are scored 0 (not reported), 1 (reported but inadequate), or 2 (reported and adequate). The global ideal score is 16 for
noncomparative studies and 24 for comparative studies.
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